Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: A double-blind randomised controlled trial

28Citations
Citations of this article
108Readers
Mendeley users who have this article in their library.

Abstract

Objective Fear of pain during intrauterine device (IUD) insertion can be a barrier to widespread use of this safe and highly effective contraceptive method. Our objective was to determine the effectiveness of topical 10% lidocaine spray for pain control during IUD insertion. Methods A total of 200 subjects with the request for IUD insertion were included in the study. The patients were randomly divided into two groups: lidocaine spray (n=100) and placebo (n=100). The pain experienced during the procedure was measured immediately after insertion by a standard Visual Analogue Scale (VAS) administered by a separate researcher with maintenance of allocation concealment. Results The mean pain score during the procedure was 1.01±1.20 in the lidocaine spray group and 3.23±1.60 in the placebo spray group (p<0.001). Lidocaine spray treatment significantly lowered the overall procedural pain score compared with placebo. Conclusions Significant pain reduction during IUD insertion can be achieved by using 10% lidocaine spray alone. Lidocaine spray can be accepted as a non-invasive, easy to apply and more comfortable local anaesthetic method for IUD insertion.

Cite

CITATION STYLE

APA

Aksoy, H., Aksoy, Ü., Ozyurt, S., Açmaz, G., & Babayigit, M. (2016). Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: A double-blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care, 42(2), 83–87. https://doi.org/10.1136/jfprhc-2014-100917

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free